Texas Children’s is pleased to announce that a three-year-old girl has been successfully treated with the first-ever FDA-approved gene therapy treatment for AADC deficiency.
Aromatic l-amino acid decarboxylase (AADC) deficiency…
Texas Children’s successfully treats AADC deficiency using FDA-approved gene therapy
